We can safely adjust your dose, switch to an alternative, or add supportive strategies all within a medically sound plan
Strengths of MEDVi's Program Affordability: Starting at $179, compounded GLP-1s are accessible compared to brand-name programs that cost thousands monthly
Semaglutide and tirzepatide are two different categories of incretin-based medications used to treat type 2 diabetes and obesity, although both are commonly grouped together in GLP-1 litigation
For example, after lowering your dose to the lowest available one, you may go from taking injections weekly, to every other week, then to every three weeks
Common side effects such as nausea, vomiting, and food aversions can further reduce intake, increasing this risk
Gastroparesis slows down gastric emptying, leading to significant discomfort and complicating the management of metabolic diseases